Biotts

The 2024 PODD conference in #Boston brought together trailblazers in pharmaceuticals, biotech, and drug delivery. We at #Biotts were thrilled to be part of this impactful event! A special thanks to everyone who attended the presentation by our CTO, Paweł Biernat, where he shared key advancements from our latest research. Thank you for the valuable discussions and networking – we're looking forward to the collaborations and innovations that lie ahead. See you next time, Boston! Let's keep pushing the boundaries in drug delivery together! #PODD2024 #partnershipopportunity #conference #transdermaldrugdelivery #insulin #diabetes 

Let's meet on 28-29 October in Boston for the #PODD2024 conference! This event brings together the business community, academia, investors and authors of the unique drug delivery technologies. Join us for a presentation by Paweł Biernat, CTO of #Biotts who will present our latest developments in #MTC-Y transdermal technology! 🗓 28.10.2024  🕞 3:52 PM  📌 TRACK 5A (MARINA BALLROOM III/IV) Find out more and set up a meeting directly with Pawel or just come and visit us in booth #110! See you in Boston! #DrugDelivery #Conference #diabetes #TransdermalDrugDelivery #Boston

🌟 Biotts will attend CPHI Milan! 🌟 It's a great chance to share ideas and meet the pharmaceutical industry. Don't miss out and schedule a meeting with Jan Henk Hendriks to find out about our latest R&D progress in transdermal diabetic projects! 🗓 October 8-10, 2024  📍 Fiera Milano, Italy #Biotts #CPHI #Milan #TransdermalDrugDelivery #Diabetes #Biotech 

Biotts will be participating in the upcoming RESI Conference in Boston! The RESI Conference brings together early-stage investors and biotech companies. It’s the perfect platform to connect with innovators and investors in the industry!  💡 Interested in exploring potential collaborations or learning more about Biotts? Don’t miss the chance to set up a meeting with our CEO, Jan Henk Hendriks.  📅 Schedule your meeting with Jan here:    https://lnkd.in/gEecZet5 #RESIBOSTON #Biotts #TransdermalDrugDeliverty #MTCY #Partnership #InvestmentOpportunity  

Did you know that #Biotts' projects are available on Inpart? It's the leading platform for scientific partnering, bringing together stakeholders from both science and business.  Interested in partnering with us? Discover how our innovative, patented transdermal technology can complement your work. We're ready to collaborate and drive innovation forward! Click and connect with us!  https://lnkd.in/dPSrkzCh  #TrasndermalDrugDelivey #MTCY 

"Experts believe many patients would have better glucose control if there was an easier way to take their #insulin. Research suggests as many as one in three sufferers hide their condition from others and often fail to test their blood sugar levels or miss insulin jabs in case they draw attention to themselves." writes lucy johnston, Health and Social Affairs Editor at the Sunday Express, in the article about our breakthrough transdermal drug delivery technology. Read more about how our transdermal insulin will make a real difference to the lives of people with #diabetes. https://lnkd.in/dUjwyDqi #SundayExpress #Diabetes #Biotts #transdermaldrugdelivery #transdermalinsulin

The history of #Biotts is inextricably linked with #Wroclaw - it is the city where the idea for the MTC-Y transdermal carrier was born and where the Biotts company was founded. We are extremely pleased and proud that on 24 June 2024 Biotts received the Mayor of Wroclaw's Award for Achievements in Scientific and Research Work for the Development of Medicine! Dr Paweł Biernat, one of our founders and CTO, accepted the award on behalf of Biotts.   #Wroclaw is a place where innovation and science go hand in hand. Thank you to everyone who supports our mission and believes in the potential of our technologies. #transdermaldrugdelivery #award

Biotts will be attending the upcoming 🌟 RESI Conference 🌟 , a premier event that brings together early stage investors, fundraising CEOs, scientist-entrepreneurs, strategic partners and service providers. Organised by Life Science Nation, this conference is a fantastic platform for showcasing disruptive technologies in the life sciences 🔬 . 🎯 Don't Miss Out: Set up a meeting with Jan Henk Hendriks to explore the transformative potential of #Biotts' patented MTC-Y transdermal drug delivery platform. Discover our latest innovations and successes in diabetes treatment and learn how our technology is set to revolutionise drug delivery. https://lnkd.in/epupPBRi #Biotts #RESIConference #LifeSciences #Innovation #Diabetes #DrugDelivery #Investors #Technology #MeetingOpportunity

We are pleased to officially confirm that the objectives of our joint PoC project with BIOTON S.A. on transdermal insulin have been met and exceeded!  Read more about these results and our future plans (including cooperation with Chardan , a global investment bank) in today's issue of Puls Biznesu in the article by Mariusz Bartodziej. #Biotts #Bioton #TransdermalDrugDelivery #Insulin #diabetes #Chardan #boost #investmentopportunity https://lnkd.in/dqat3fDR

This week marks the beginning of the XXV Congress of the Polish Diabetology Association, which will take place from 23 to 25 May in Warsaw. This is one of the most important events for all professionals who provide comprehensive help to people struggling with diabetes and its consequences. We'd like to invite you to a presentation by our CTO, Paweł Biernat, on 25 May at 8:30 in Hall H4. He will be talking about alternative methods of delivering anti-diabetic agents using an innovative transdermal carrier. Find out more about this event: https://www.25ptd.pl #Biotts #Congress #Diabetes #TransdermalDrugDelivery #MTCY #PolishDiabetologyAssociation